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Aims and objective: Despite effective treatment of pulmonary tuberculosis (TB) patients,
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destruction of lung parenchyma may lead to complications including repeated infections.
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These infections are often misdiagnosed or wrongly identified as TB recurrence, and hence
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are not treated effectively. The frequency and severity of these infections vary with the
extent of damage, and are much more prominent in patients with post-TB bronchiectasis
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and fibrocavitary diseases. This presentation will focus on the epidemiology, treatment,

Post TB infections

and management of post-TB infections and challenges, and the impact of these infections

Chronic pulmonary aspergillosis

on public health in high-TB-burden countries.

Non tuberculous mycobacterial

Methods: Published literature and review articles were evaluated to address this objective.

infections

Results: Apart from conventional agents of pneumonia, patients with post-TB bronchiecta-

Developing countries

sis and post-TB fibrocavitary diseases are prone to develop chronic pulmonary aspergillosis
and nontuberculous mycobacterial infections. A high burden of chronic pulmonary
aspergillosis has been reported in TB-endemic countries. Similarly, prior TB increases the
risk of acquiring nontuberculous mycobacterial infections. Diagnosis and management
of chronic pulmonary aspergillosis and nontuberculous mycobacterial infections require
expertise and high-level care.
Conclusion: Limited diagnostic and therapeutic capacities compounded by nonavailability
of essential antimicrobials in most high-TB-burden countries pose great challenges to
physicians involved in the management of these infections. These infections affect the
overall outcome and lead to high cost for public health systems.
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